Leukocyte Reduction Should Be Done Prior To Transfusions - FDA Safety Alert
This article was originally published in The Gray Sheet
Blood products that are leukocyte-reduced at the time of collection or during the laboratory storage period should be used for all patients requiring leukocyte-reduced blood products "whenever feasible," FDA says in a May 4 safety alert.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.